Skip to content
10-K

Annual Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-26-000241

← back to feed
Filed
Feb 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 31, 2026 60.04M sh
Shares Diluted FY 2025 · Dec 31, 2025 60.04M sh
Shares Diluted FY 2025 · Dec 31, 2024 60.04M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$196.3K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$36.69K
Stockholders Equity FY 2025 · Dec 31, 2025 −$386.96K
Stockholders Equity FY 2025 · Dec 31, 2024 −$294.97K
Stockholders Equity FY 2025 · Dec 31, 2023 −$257.01K
Current Liabilities FY 2025 · Dec 31, 2025 $401.06K
Current Liabilities FY 2025 · Dec 31, 2024 $326.95K
Current Assets FY 2025 · Dec 31, 2025 $14.1K
Current Assets FY 2025 · Dec 31, 2024 $5.08K
Total Assets FY 2025 · Dec 31, 2025 $14.1K
Total Assets FY 2025 · Dec 31, 2024 $31.97K
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 $0.00
Sga Expense FY 2025 · Dec 31, 2025 $154.02K
Sga Expense FY 2025 · Dec 31, 2024 $37.96K
Net Income FY 2025 · Dec 31, 2025 −$101.15K
Net Income FY 2025 · Dec 31, 2024 −$42.3K
Operating Income FY 2025 · Dec 31, 2025 −$154.02K
Operating Income FY 2025 · Dec 31, 2024 −$37.96K
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0